tiprankstipranks
Advertisement
Advertisement
Climb Bio Reports Encouraging Early Budoprutug ITP Data
PremiumCompany AnnouncementsClimb Bio Reports Encouraging Early Budoprutug ITP Data
1M ago
Climb Bio Shareholders Approve Equity Plan Amendment, Reelect Directors
Premium
Company Announcements
Climb Bio Shareholders Approve Equity Plan Amendment, Reelect Directors
1M ago
Climb Bio initiated with a Buy at Guggenheim
Premium
The Fly
Climb Bio initiated with a Buy at Guggenheim
1M ago
Climb Bio price target raised to $17 from $15 at Wedbush
PremiumThe FlyClimb Bio price target raised to $17 from $15 at Wedbush
2M ago
Climb Bio reports Q1 EPS (20c), consensus (31c)
Premium
The Fly
Climb Bio reports Q1 EPS (20c), consensus (31c)
2M ago
Climb Bio price target raised to $21 from $12 at Baird
Premium
The Fly
Climb Bio price target raised to $21 from $12 at Baird
2M ago
Climb Bio management to meet with Piper Sandler
PremiumThe FlyClimb Bio management to meet with Piper Sandler
3M ago
Climb Bio Raises $110 Million in Private Placement
Premium
Company Announcements
Climb Bio Raises $110 Million in Private Placement
3M ago
Climb Bio to sell 9.481M shares at $9.50 in private placement
Premium
The Fly
Climb Bio to sell 9.481M shares at $9.50 in private placement
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100